Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues
05 janv. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®
21 déc. 2020 07h30 HE
|
Profound Medical Corp.
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical Receives FDA HDE Approval for Sonalleve®
30 nov. 2020 08h00 HE
|
Profound Medical Corp.
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) announced today that Sonalleve® has received U.S. Food and Drug Administration...
Profound Medical Announces Changes to its Board of Directors
30 nov. 2020 07h45 HE
|
Profound Medical Corp.
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical to Participate in November Virtual Investor Healthcare Conferences
10 nov. 2020 16h30 HE
|
Profound Medical Corp.
TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical Announces Third Quarter 2020 Financial Results
05 nov. 2020 16h02 HE
|
Profound Medical Corp.
TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical to Release Third Quarter 2020 Financial Results on November 5 – Conference Call to Follow
15 oct. 2020 16h30 HE
|
Profound Medical Corp.
TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical to Present at the Cantor Virtual Global Healthcare Conference
09 sept. 2020 16h30 HE
|
Profound Medical Corp.
TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference
10 août 2020 08h00 HE
|
Profound Medical Corp.
TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical Announces Second Quarter 2020 Financial Results
06 août 2020 16h02 HE
|
Profound Medical Corp.
TORONTO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...